Wesbanco Bank Inc Bristol Myers Squibb CO Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wesbanco Bank Inc holds 269,176 shares of BMY stock, worth $15.5 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

269,176

Previous 275,912 2.44%

Holding current value

$15.5 Million

Previous $11.5 Million 21.57%

% of portfolio

0.48%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$39.66 - $51.75 $267,149 - $348,588	-6,736 Reduced 2.44%	269,176 $13.9 Million
Q2 2024 Jul 11, 2024	SELL	$40.25 - $52.99 $581,612 - $765,705	-14,450 Reduced 4.98%	275,912 $11.5 Million
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $1.05 Million - $1.19 Million	21,842 Added 8.13%	290,362 $15.7 Million
Q4 2023 Feb 16, 2024	SELL	$48.48 - $57.85 $1.7 Million - $2.03 Million	-35,125 Reduced 11.57%	268,520 $13.8 Million
Q3 2023 Dec 11, 2023	SELL	$57.89 - $64.73 $547,755 - $612,475	-9,462 Reduced 3.02%	303,645 $17.6 Million
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $269,811 - $299,583	-4,235 Reduced 1.33%	313,107 $20 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $207,643 - $235,514	-3,160 Reduced 0.99%	317,342 $22 Million
Q4 2022 Jan 18, 2023	BUY	$68.48 - $81.09 $2 Million - $2.36 Million	29,160 Added 10.01%	320,502 $23.1 Million
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $8,107 - $4.79 Million	-62,363 Reduced 17.63%	291,342 $20.7 Million
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $319,891 - $352,311	-4,405 Reduced 1.23%	353,705 $27.2 Million
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $5.37 Million - $6.44 Million	-87,373 Reduced 19.61%	358,110 $26.2 Million
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $43,493 - $50,703	811 Added 0.18%	445,483 $27.8 Million
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $3.61 Million - $4.23 Million	61,003 Added 15.9%	444,672 $26.3 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $126,296 - $137,536	-2,040 Reduced 0.53%	383,669 $25.6 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $639,210 - $718,923	-10,772 Reduced 2.72%	385,709 $24.3 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $212,720 - $235,722	-3,704 Reduced 0.93%	396,481 $23.9 Million
Q2 2020 Jul 14, 2020	SELL	$54.82 - $64.09 $241,920 - $282,829	-4,413 Reduced 1.09%	400,185 $23.5 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $238,867 - $347,129	-5,148 Reduced 1.26%	404,598 $22.6 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $354,754 - $462,745	7,209 Added 1.79%	409,746 $26.3 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $296,567 - $351,623	-6,934 Reduced 1.69%	402,537 $20.4 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $172,857 - $191,143	-3,874 Reduced 0.94%	409,471 $18.6 Million
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $1.63 Million - $1.94 Million	-36,074 Reduced 8.03%	413,345 $19.7 Million
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $1.21 Million - $1.56 Million	-24,750 Reduced 5.22%	449,419 $23.4 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $13,080 - $14,753	-237 Reduced 0.05%	474,169 $29.4 Million
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $127,891 - $159,402	2,531 Added 0.54%	474,406 $26.3 Million
Q1 2018 May 18, 2018	BUY	$59.92 - $68.98 $1.15 Million - $1.33 Million	19,224 Added 4.25%	471,875 $29.8 Million
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $2.26 Million - $2.47 Million	-37,726 Reduced 7.69%	452,651 $27.7 Million
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $147,464 - $170,185	2,670 Added 0.55%	490,377 $31.3 Million
Q2 2017 Aug 08, 2017	BUY	N/A	487,707	487,707 $27.2 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Bristol Myers Squibb CO Transaction History